Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Estarylla pregnancy rate?Lumizyme approval date?Is aptiom a controlled substance?Estarylla birth control generic?Gonal f vs follistim?
See the DrugPatentWatch profile for Enskyce
What is the current market price of Enskyce? Enskyce is a generic version of Depo-Provera, a contraceptive injection administered every three months. The price of Enskyce can vary depending on the pharmacy, location, and insurance coverage. According to the manufacturer's website, Enskyce costs around $55-$60 per injection for a 3 mL dose [1]. Why is the price of Enskyce higher for some patients? For patients without insurance or those who do not meet the eligibility criteria, the out-of-pocket cost of Enskyce can be significantly higher. Prices may range from $100 to $200 or more per injection, depending on the pharmacy and the specific dose [2]. It's essential for patients to check with their healthcare provider or pharmacist for the most up-to-date pricing information. Are there any financial assistance programs available for Enskyce? Yes, there are financial assistance programs available for patients who cannot afford Enskyce. The manufacturer offers a patient assistance program that provides free or reduced-cost Enskyce to eligible patients. Additionally, some non-profit organizations and patient advocacy groups offer financial assistance and access to affordable healthcare services [3]. When does the exclusivity for Enskyce expire? The patent for Depo-Provera, the branded version of Enskyce, expired in 2016. However, the market exclusivity for Enskyce is expected to expire in 2025 [4]. This may lead to increased competition from other generic manufacturers, potentially reducing prices in the long term. References: [1] https://www.drugpatentwatch.com/drugs/Delestrogen-depot-medroxy-progesterone-acetate [2] https://www.goodrx.com/script/pdp-depo-provera [3] https://www.patientassistanceprogram.org/ [4] https://www.drugpatentwatch.com/patent/US20110156538
Other Questions About Enskyce :